Marijuana: An Underappreciated Risk Factor for Acute Type A Aortic Dissection?
DOI:
https://doi.org/10.1532/hsf.3409Keywords:
aortic dissection, marijuana, tetrahydrocannabinol (THC), toxicologyAbstract
Background: Stimulants such as cocaine and amphetamines are well-established risk factors for acute aortic dissection. Despite the fact that marijuana is the most commonly used illicit drug in the United States, its relationship to acute aortic syndromes has not been well studied.
Methods: A comprehensive retrospective review was undertaken of all consecutive patients who presented with acute Stanford type A aortic dissection from January 2017 to December 2019. Of 152 patients identified, 51 (33.6%) underwent comprehensive urine toxicology screening at clinical presentation. The characteristics and outcomes of the patients with urine results positive for tetrahydrocannabinol (THC) (n = 9, 17.6%) were compared with the 42 patients who had no evidence of recent marijuana consumption.
Results: Of the 51 dissection patients who underwent broad-spectrum urine toxicology screening upon presentation, 9 (17.6%) returned positive results for THC, a proportion higher than would be expected for the general population. All THC patients were male; 3 concurrently tested positive for cocaine, and 3 others had evidence of recent amphetamine use. The THC patients were significantly younger than the non-THC patients (mean ± standard deviation age 48 ± 11.3 versus 61.4 ± 12.3 years, respectively, P = .004). A greater proportion of the THC cohort had a known diagnosis of aortic aneurysm before the dissection (44.4% versus 4.8%, P = .006). All patients underwent expeditious surgical repair. Thirty-day mortality for the entire cohort of 51 patients was 19.6% (10 deaths); for the THC group, it was 11.1% (1 death). There was no difference in the incidence of major postoperative complications between the 2 groups.
Conclusion: Marijuana is the third most commonly used substance in the United States, after alcohol and tobacco. Although marijuana use is understudied, our results suggest that marijuana may be a contributing risk factor for acute type A aortic dissection, particularly in patients with other predisposing risk factors. Given the recent national trend to legalize marijuana, with the concomitant potential for exponential increases in its consumption, we suggest that the diagnosis of aortic dissection be considered earlier in any younger patient who presents with suggestive symptoms, especially if there is a history of recent marijuana use.
References
Barry RA, Glantz SA. Marijuana regulatory frameworks in four US states: An analysis against a public health standard. Am J Public Health 2018;108:914-923.
Carliner H, Brown QL, Sarvet AL, Hasin DS. Cannabis use, attitudes, and legal status in the U.S.: A review. Prev Med 2017;104:13-23.
Chase PB, Hawkins J, Mosier J, et al. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs. Clin Toxicol (Phila) 2016;54:14-19.
DeFilippis EM, Bajaj NS, Singh A, et al. Marijuana use in patients with cardiovascular disease. J Am Coll Cardiol 2020;75:320-332.
Desbois AC, Cacoub P. Cannabis-associated arterial disease. Ann Vasc Surg 2013;27:996-1005.
Eagle KA, Isselbacher EM, DeSanctis RW, International Registry for Aortic Dissection (IRAD) Investigators. Cocaine-related aortic dissection in perspective. Circulation 2002;105:1529-1530.
Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. A survey of synthetic cannabinoid consumption by current cannabis users. Subst Abus 2014;35:184-189.
Hall W, Stjepanović D, Caulkins J, et al. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. Lancet 2019;394:1580-1590.
Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-381.
Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacology 2018;43:195-212.
Hemli JM, DeLaney ER, Dholakia KR, et al. Rethinking the paradigm: Modern approach to proximal aortic reconstruction demonstrates excellent outcomes. Heart Surg Forum 2017;20:E092-E097.
Kilmer B. Recreational cannabis—Minimizing the health risks from legalization. N Engl J Med 2017;376:705-707.
Lindsay AC, Foale RA, Warren O, Henry JA. Cannabis as a precipitant of cardiovascular emergencies. Int J Cardiol 2005;104:230-232.
Lukas SE, Sholar M, Kouri E, Fukuzako H, Mendelson JH. Marihuana smoking increases plasma cocaine levels and subjective reports of euphoria in male volunteers. Pharmacol Biochem Behav 1994;48:715-721.
Martz G, Tankersley W, Mekala HM, Motiwala H. Rates of synthetic cannabinoid use in adolescents admitted to a treatment facility. Prim Care Companion CNS Disord 2018;20:17m02265.
Mason EK, Gak AE, Finno JG, Cannon RD, Jacoby JL. Thoracic aortic dissection associated with marijuana use. J Emerg Med 2019;57:235-237.
Maxwell JC, Mendelson B. What do we know now about the impact of the laws related to marijuana? J Addict Med 2016;10:3-12.
Mead A. Legal and regulatory issues governing cannabis and cannabis-derived products in the United States. Front Plant Sci 2019;10:697.
Mittlemen MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation 2001;103:2805-2809.
Oberbarnscheidt T, Miller NS. The impact of cannabidiol on psychiatric and medical conditions. J Clin Med Res 2020;12:393-403.
Palamar JJ, Barratt MJ. Synthetic cannabinoids: Undesirable alternatives to natural marijuana. Am J Drug Alcohol Abuse 2016;42:371-373.
ProCon.org. Legal Medical Marijuana States and DC. 2020. Available at https://medicalmarijuana.procon.org/legal-medical-marijuana-states-and-dc/ (Accessed January 27, 2021).
Richards JR, Bing ML, Moulin AK, et al. Cannabis use and acute coronary syndrome. Clin Toxicol 2019;57:831-841.
SAMHSA (Substance Abuse and Mental Health Services Administration). Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). 2019. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Available at: http://store.samhsa.gov/product/key-substance-use-and-mental-health-indicators-in-the-united-states-results-from-the-2018-national-survey-on-Drug-Use-and-Health/PEP19-5068 (Accessed January 27, 2021).
Sevigny EL, Pacula RL, Heaton P. The effects of medical marijuana laws on potency. Int J Drug Policy 2014;25:308-319.
Shah R, Berzingi C, Fan THM, Askari R, Khan MR. Cocaine-induced acute aortic dissection. J Emerg Med 2015;49:e87-e89.
Sznitman SR, Bretteville-Jensen AL. Public opinion and medical cannabis policies: Examining the role of underlying beliefs and national medical cannabis policies. Harm Reduct J 2015;12:46.
Wako E, LeDoux D, Mitsumori L, Aldea GS. The emerging epidemic of methamphetamine-induced aortic dissections. J Card Surg 2007;22:390-393.
Zvonarev V, Fatuki TA, Tregubenko P. The public health concerns of marijuana legalization: An overview of current trends. Cureus 2019;11:e5806
